Literature DB >> 29423003

Direct conversion of human fibroblasts into functional Leydig-like cells by SF-1, GATA4 and NGFI-B.

Yan-Ping Hou1, Zhi-Yuan Zhang1, Xiao-Yu Xing1, Jin Zhou1, Jie Sun1.   

Abstract

The reprogramming of fibroblasts to induced pluripotent stem cells raises the possibility that a somatic cell can be reprogrammed to an alternative, differentiated fate without first becoming a stem/progenitor cell. Recent work has shown that fibroblasts can be reprogrammed to other, terminally differentiated cells with a combination of several transcription factors. Here, we report that a combination of four developmental transcription factors; GATA4, SF-1, NGFI-B, and COUP TF2; efficiently reprogrammed human foreskin fibroblasts into functional induced Leydig-like cells (iLCs). The iLCs expressed Leydig-specific markers and secreted testosterone in vitro. We found that GATA4 and SF-1 were particularly critical for Leydig-specific markers expression and that GATA4, SF-1, and NGFI-B were necessary to generate functional iLCs that secreted testosterone. These findings demonstrate that fibroblasts can be directly converted into iLCs with a few, defined factors and may provide insight into potential therapies to treat testosterone deficiency.

Entities:  

Keywords:  Human foreskin fibroblasts; induced Leydig-like cells; reprogramming

Year:  2018        PMID: 29423003      PMCID: PMC5801356     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  37 in total

Review 1.  Role of the GATA family of transcription factors in andrology.

Authors:  Robert S Viger; Hiroaki Taniguchi; Nicholas M Robert; Jacques J Tremblay
Journal:  J Androl       Date:  2004 Jul-Aug

2.  Testosterone propionate therapy in one hundred cases of angina pectoris.

Authors:  M A LESSER
Journal:  J Clin Endocrinol Metab       Date:  1946-08       Impact factor: 5.958

3.  Directed mouse embryonic stem cells into leydig-like cells rescue testosterone-deficient male rats in vivo.

Authors:  Yan Yang; Zhijian Su; Wenting Xu; Jiao Luo; Rui Liang; Qi Xiang; Qihao Zhang; Ren-shan Ge; Yadong Huang
Journal:  Stem Cells Dev       Date:  2014-12-18       Impact factor: 3.272

4.  Nuclear receptor steroidogenic factor 1 directs embryonic stem cells toward the steroidogenic lineage.

Authors:  P A Crawford; Y Sadovsky; J Milbrandt
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 5.  Stem cell differentiation into steroidogenic cell lineages by NR5A family.

Authors:  Kaoru Miyamoto; Takashi Yazawa; Tetsuya Mizutani; Yoshitaka Imamichi; Shin-ya Kawabe; Masafumi Kanno; Takahiro Matsumura; Yunfeng Ju; Akihiko Umezawa
Journal:  Mol Cell Endocrinol       Date:  2010-12-04       Impact factor: 4.102

Review 6.  Steroidogenic factor 1: an essential mediator of endocrine development.

Authors:  Keith L Parker; Douglas A Rice; Deepak S Lala; Yayoi Ikeda; Xunrong Luo; Margaret Wong; Marit Bakke; Liping Zhao; Claudia Frigeri; Neil A Hanley; Nancy Stallings; Bernard P Schimmer
Journal:  Recent Prog Horm Res       Date:  2002

7.  GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5.

Authors:  Vidu Garg; Irfan S Kathiriya; Robert Barnes; Marie K Schluterman; Isabelle N King; Cheryl A Butler; Caryn R Rothrock; Reenu S Eapen; Kayoko Hirayama-Yamada; Kunitaka Joo; Rumiko Matsuoka; Jonathan C Cohen; Deepak Srivastava
Journal:  Nature       Date:  2003-07-06       Impact factor: 49.962

Review 8.  Leydig cells: From stem cells to aging.

Authors:  Haolin Chen; Ren-Shan Ge; Barry R Zirkin
Journal:  Mol Cell Endocrinol       Date:  2009-02-07       Impact factor: 4.102

9.  Direct conversion of fibroblasts into functional astrocytes by defined transcription factors.

Authors:  Massimiliano Caiazzo; Serena Giannelli; Pierluigi Valente; Gabriele Lignani; Annamaria Carissimo; Alessandro Sessa; Gaia Colasante; Rosa Bartolomeo; Luca Massimino; Stefano Ferroni; Carmine Settembre; Fabio Benfenati; Vania Broccoli
Journal:  Stem Cell Reports       Date:  2014-12-31       Impact factor: 7.765

10.  In vivo reprogramming of adult pancreatic exocrine cells to beta-cells.

Authors:  Qiao Zhou; Juliana Brown; Andrew Kanarek; Jayaraj Rajagopal; Douglas A Melton
Journal:  Nature       Date:  2008-08-27       Impact factor: 49.962

View more
  7 in total

1.  Adaptation of Human Testicular Niche Cells for Pluripotent Stem Cell and Testis Development Research.

Authors:  Marina V Pryzhkova; Philip W Jordan
Journal:  Tissue Eng Regen Med       Date:  2020-02-29       Impact factor: 4.169

Review 2.  Transcription Factors in the Regulation of Leydig Cell Gene Expression and Function.

Authors:  Karine de Mattos; Robert S Viger; Jacques J Tremblay
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-07       Impact factor: 6.055

3.  CRISPR/dCas9-mediated activation of multiple endogenous target genes directly converts human foreskin fibroblasts into Leydig-like cells.

Authors:  Hua Huang; Xiangyu Zou; Liang Zhong; Yanping Hou; Jin Zhou; Zhiyuan Zhang; Xiaoyu Xing; Jie Sun
Journal:  J Cell Mol Med       Date:  2019-07-02       Impact factor: 5.310

4.  Leydig-like cells derived from reprogrammed human foreskin fibroblasts by CRISPR/dCas9 increase the level of serum testosterone in castrated male rats.

Authors:  Hua Huang; Liang Zhong; Jin Zhou; Yanping Hou; Zhiyuan Zhang; Xiaoyu Xing; Jie Sun
Journal:  J Cell Mol Med       Date:  2020-03-11       Impact factor: 5.310

Review 5.  Generation of Leydig-like cells: approaches, characterization, and challenges.

Authors:  Zhao-Hui Li; Jun-Dong Lu; Shi-Jun Li; Hao-Lin Chen; Zhi-Jian Su
Journal:  Asian J Androl       Date:  2022 Jul-Aug       Impact factor: 3.054

Review 6.  Stem Leydig Cells in the Adult Testis: Characterization, Regulation and Potential Applications.

Authors:  Panpan Chen; Barry R Zirkin; Haolin Chen
Journal:  Endocr Rev       Date:  2020-02-01       Impact factor: 19.871

Review 7.  Rebuilding Tendons: A Concise Review on the Potential of Dermal Fibroblasts.

Authors:  Jin Chu; Ming Lu; Christian G Pfeifer; Volker Alt; Denitsa Docheva
Journal:  Cells       Date:  2020-09-08       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.